rs41273619
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006218.4(PIK3CA):c.1747-13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0481 in 1,268,272 control chromosomes in the GnomAD database, including 1,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.051 ( 211 hom., cov: 32)
Exomes 𝑓: 0.048 ( 1367 hom. )
Consequence
PIK3CA
NM_006218.4 intron
NM_006218.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.80
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-179219558-T-C is Benign according to our data. Variant chr3-179219558-T-C is described in ClinVar as [Benign]. Clinvar id is 259959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-179219558-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0557 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0510 AC: 7748AN: 151960Hom.: 212 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7748
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0469 AC: 10621AN: 226646 AF XY: 0.0470 show subpopulations
GnomAD2 exomes
AF:
AC:
10621
AN:
226646
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0478 AC: 53307AN: 1116194Hom.: 1367 Cov.: 14 AF XY: 0.0471 AC XY: 26727AN XY: 567718 show subpopulations
GnomAD4 exome
AF:
AC:
53307
AN:
1116194
Hom.:
Cov.:
14
AF XY:
AC XY:
26727
AN XY:
567718
Gnomad4 AFR exome
AF:
AC:
1066
AN:
26012
Gnomad4 AMR exome
AF:
AC:
1549
AN:
39272
Gnomad4 ASJ exome
AF:
AC:
1968
AN:
22842
Gnomad4 EAS exome
AF:
AC:
2
AN:
37776
Gnomad4 SAS exome
AF:
AC:
925
AN:
75596
Gnomad4 FIN exome
AF:
AC:
3191
AN:
52380
Gnomad4 NFE exome
AF:
AC:
41939
AN:
808950
Gnomad4 Remaining exome
AF:
AC:
2426
AN:
48376
Heterozygous variant carriers
0
2487
4974
7461
9948
12435
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1250
2500
3750
5000
6250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0510 AC: 7749AN: 152078Hom.: 211 Cov.: 32 AF XY: 0.0508 AC XY: 3774AN XY: 74354 show subpopulations
GnomAD4 genome
AF:
AC:
7749
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
3774
AN XY:
74354
Gnomad4 AFR
AF:
AC:
0.0417188
AN:
0.0417188
Gnomad4 AMR
AF:
AC:
0.0510217
AN:
0.0510217
Gnomad4 ASJ
AF:
AC:
0.086944
AN:
0.086944
Gnomad4 EAS
AF:
AC:
0.0003861
AN:
0.0003861
Gnomad4 SAS
AF:
AC:
0.0116134
AN:
0.0116134
Gnomad4 FIN
AF:
AC:
0.0741929
AN:
0.0741929
Gnomad4 NFE
AF:
AC:
0.0571904
AN:
0.0571904
Gnomad4 OTH
AF:
AC:
0.0687204
AN:
0.0687204
Heterozygous variant carriers
0
368
736
1105
1473
1841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sep 06, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Jul 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Cowden syndrome 5 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cowden syndrome Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at